A novel CD123-targeted therapeutic peptide loaded by micellar delivery system combats refractory acute myeloid leukemia

Acute myeloid leukemia (AML) is a common malignant heterogeneous hematopoietic disease with very low average 5-year survival rate due to the refractory feature and high rate of relapse. CD123 is highly expressed on multiple types of AML cells, especially leukemia stem cells, and closely associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Shilin, Zhang, Meichen, Fang, Xiaocui, Meng, Jie, Xing, Haiyan, Yan, Doudou, Liu, Jian, Yang, Yanlian, Wen, Tao, Zhang, Weiqi, Wang, Jianxiang, Wang, Chen, Xu, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590286/
https://www.ncbi.nlm.nih.gov/pubmed/34774070
http://dx.doi.org/10.1186/s13045-021-01206-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590286/
https://www.ncbi.nlm.nih.gov/pubmed/34774070
http://dx.doi.org/10.1186/s13045-021-01206-y

Ejemplares similares